IL187827A0 - Identification of novel bitter taste receptor t2r76 that specifically responds to brucine and prop bitter ligands - Google Patents

Identification of novel bitter taste receptor t2r76 that specifically responds to brucine and prop bitter ligands

Info

Publication number
IL187827A0
IL187827A0 IL187827A IL18782707A IL187827A0 IL 187827 A0 IL187827 A0 IL 187827A0 IL 187827 A IL187827 A IL 187827A IL 18782707 A IL18782707 A IL 18782707A IL 187827 A0 IL187827 A0 IL 187827A0
Authority
IL
Israel
Prior art keywords
bitter
brucine
prop
identification
novel
Prior art date
Application number
IL187827A
Other languages
English (en)
Original Assignee
Senomyx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senomyx Inc filed Critical Senomyx Inc
Publication of IL187827A0 publication Critical patent/IL187827A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
IL187827A 2005-07-18 2007-12-03 Identification of novel bitter taste receptor t2r76 that specifically responds to brucine and prop bitter ligands IL187827A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/182,942 US20060019346A1 (en) 2002-07-29 2005-07-18 Identification of a novel bitter taste receptor T2R76 that specifically responds to brucine and prop bitter ligands
PCT/US2006/027656 WO2007011859A2 (en) 2005-07-18 2006-07-17 Identification of a novel bitter taste receptor t2r76 that specifically responds to brucine and prop bitter ligands

Publications (1)

Publication Number Publication Date
IL187827A0 true IL187827A0 (en) 2008-03-20

Family

ID=37669462

Family Applications (1)

Application Number Title Priority Date Filing Date
IL187827A IL187827A0 (en) 2005-07-18 2007-12-03 Identification of novel bitter taste receptor t2r76 that specifically responds to brucine and prop bitter ligands

Country Status (10)

Country Link
US (1) US20060019346A1 (https=)
EP (1) EP1904527A4 (https=)
JP (1) JP2009514507A (https=)
CN (1) CN101595118A (https=)
AU (1) AU2006270110A1 (https=)
CA (1) CA2610237A1 (https=)
IL (1) IL187827A0 (https=)
MX (1) MX2007015930A (https=)
NO (1) NO20076201L (https=)
WO (1) WO2007011859A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004011617A2 (en) * 2002-07-29 2004-02-05 Senomyx, Inc. Identification of a novel bitter taste receptor, t2r76
WO2006068745A1 (en) 2004-12-22 2006-06-29 Cargill, Incorporated Methods for determining cellular response to stimuli
WO2008008224A2 (en) 2006-07-10 2008-01-17 Duke University Sour taste receptor compositions and methods
EP2245171A2 (en) * 2008-02-01 2010-11-03 Chromocell Corporation Cell lines and methods for making and using them
US8557530B2 (en) 2008-08-29 2013-10-15 Givaudan Sa Use of a TAS2R7 nucleic acid sequence to identify modulators
CN103068380A (zh) * 2010-06-17 2013-04-24 加州理工学院 用于调节激素的方法和系统以及相关的方法、剂和组合物
HUE051738T2 (hu) 2011-01-07 2021-03-29 Anji Pharma Us Llc Kemoszenzoros receptorligandum-alapú terápiák
US9795792B2 (en) 2011-02-25 2017-10-24 Medtronic, Inc. Emergency mode switching for non-pacing modes
KR20200137035A (ko) 2012-01-06 2020-12-08 앤지 파마 유에스 엘엘씨 바이구아나이드 조성물 및 대사 장애를 치료하는 방법
EA033067B1 (ru) 2012-01-06 2019-08-30 Элселикс Терапьютикс, Инк. Способ лечения метаболических расстройств у пациента, имеющего противопоказание к назначению бигуанидного соединения
CA2878625A1 (en) 2012-07-11 2014-01-16 Elcelyx Therapeutics, Inc. Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
CN105101956B (zh) 2013-01-05 2018-12-07 埃尔舍利克斯治疗公司 包含双胍的延迟释放组合物
EP4566459A3 (en) * 2018-08-10 2025-08-20 Firmenich Incorporated Antagonists of t2r54 and compositions and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004808A (en) * 1996-06-21 1999-12-21 Aurora Biosciences Corporation Promiscuous G-protein compositions and their use
JP2003057981A (ja) * 2001-08-17 2003-02-28 Nitto Kogyo Co Ltd 定着装置
WO2004011617A2 (en) * 2002-07-29 2004-02-05 Senomyx, Inc. Identification of a novel bitter taste receptor, t2r76

Also Published As

Publication number Publication date
WO2007011859A2 (en) 2007-01-25
EP1904527A2 (en) 2008-04-02
CA2610237A1 (en) 2007-01-25
MX2007015930A (es) 2008-03-06
EP1904527A4 (en) 2010-05-05
AU2006270110A1 (en) 2007-01-25
JP2009514507A (ja) 2009-04-09
NO20076201L (no) 2008-04-17
WO2007011859A3 (en) 2009-08-27
US20060019346A1 (en) 2006-01-26
CN101595118A (zh) 2009-12-02

Similar Documents

Publication Publication Date Title
IL187827A0 (en) Identification of novel bitter taste receptor t2r76 that specifically responds to brucine and prop bitter ligands
ZA200707482B (en) Compounds comprising linked heteroaryl moieties and their use as novel umami flavour modifiers, tastants and taste enhancers for comestible compositions
IL189383A0 (en) Derivatives of 4-piperazin-1-yl
PL1745702T3 (pl) Wytwarzanie rozpuszczalnej kawy za pomocą enzymów
ZA200902393B (en) Preparation of azoxystrobin
ZA200701305B (en) Fastening element for end areas of garments to be fastened to one another
ZA200806076B (en) Assessment of diamond color
IL207922A0 (en) Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers
EP2095718A4 (en) TEA EXTRACT
GB0719545D0 (en) Novel use of cocoa extract
EP1946648A4 (en) PROCESS FOR PRODUCING COFFEE EXTRACT
ZA200608914B (en) Method for improved breast milk to reduce the risk of allergy
IL185413A0 (en) Tin mediated regioselective synthesis of sucrose-6-esters
GB0421830D0 (en) Process for making tea extracts
GB0421832D0 (en) Process for making tea extracts
PL1872665T3 (pl) Sposób modyfikacji smaku kawy
EP1912499A4 (en) PREPARATION OF MONTELUKAST
EP2375911A4 (en) CHOCOLATE EXTRACT, METHOD OF MAKING SAME, AND USES THEREOF
EP1922548A4 (en) PROCEDURE FOR HEMOGLOBIN CORRECTION ON THE BASIS OF TEMPERATURE VARIATIONS
GB0411682D0 (en) Display of enhanced content
EP1870349A4 (en) CAPSULE CONTAINING MOLDED PRODUCTS FOR OBTAINING INFUSIONS
EP1949217A4 (en) API INTERFACE FOR ARBORESCENCE MEMORY SYSTEM FOR INTERLOCKING KNOWLEDGE BASES
GB2410172B (en) Chocolate flavour extract
GB0511972D0 (en) Tea product
GB0411172D0 (en) Display of enhanced content